Inactive Instrument

Highlights Alta Natural Herbs & Supplements Ltd Toronto S.E.

Equities

CA0209261019

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2024	03-26	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2023	02-27	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	26/09/23	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	26/06/23	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2022	27/02/23	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	14/09/22	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	28/06/22	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2022	25/03/22	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2021	28/02/22	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended July 31, 2021	21/09/21	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ended April 30, 2021	25/06/21	CI
Genix Pharmaceuticals : Starts Trading on OTCQB Venture Market Exchange	21/06/21	MT
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for First Generic Thyroid Medication	01/04/21	CI
Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions for its First Ten Ophthalmic Drugs with Health Canada	22/03/21	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2020	28/02/21	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended July 31, 2020	29/09/20	CI
Genix Pharmaceuticals Corporation completed the acquisition of global distribution, sales and marketing rights and interest for Flu-X(r) from Canagen Pharmaceuticals Inc.	27/09/20	CI
Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2020	26/03/20	CI
Genix Pharmaceuticals Corporation entered into a definitive agreement to acquire global distribution, sales and marketing rights and interest for Flu-X(r) from Canagen Pharmaceuticals Inc. for CAD 0.1 million.	26/03/20	CI
Genix Pharmaceuticals Corporation Enters into an Exclusive Global Distribution Agreement with Canagen Pharmaceuticals Inc	26/03/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alta Natural Herbs & Supplements Ltd Toronto S.E.

Equities

CA0209261019

Highlights

Filters